Federal cannabis rescheduling from Schedule I to III would reduce tax burdens by eliminating Section 280E, improve banking access, and enable more research—but won’t legalize cannabis nationwide or allow interstate sales. Washington consumers may see lower prices, better financial stability for retailers, and a more mature, regulated market.
Read More